Literature DB >> 31189730

Turning subtypes into disease axes to improve prediction of COPD progression.

Junxiang Chen1, Michael Cho2,3, Edwin K Silverman2,3, John E Hokanson4, Greg L Kinney4, James D Crapo5, Stephen Rennard6,7, Jennifer Dy1, Peter Castaldi8,9.   

Abstract

Chronic obstructive pulmonary disease (COPD) is an umbrella definition encompassing multiple disease processes. COPD heterogeneity has been described as distinct subgroups of individuals (subtypes) or as continuous measures of COPD variability (disease axes). There is little consensus on whether subtypes or disease axes are preferred, and the relative value of disease axes and subtypes for predicting COPD progression is unknown. Using a propensity score approach to learn disease axes from pairs of subtypes, we demonstrate that these disease axes predict prospective forced expiratory volume in 1 s decline and emphysema progression more accurately than the subtype pairs from which they were derived. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  copd epidemiology; emphysema

Mesh:

Year:  2019        PMID: 31189730      PMCID: PMC7500804          DOI: 10.1136/thoraxjnl-2018-213005

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

1.  Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts.

Authors:  Peter J Castaldi; Marta Benet; Hans Petersen; Nicholas Rafaels; James Finigan; Matteo Paoletti; H Marike Boezen; Judith M Vonk; Russell Bowler; Massimo Pistolesi; Milo A Puhan; Josep Anto; Els Wauters; Diether Lambrechts; Wim Janssens; Francesca Bigazzi; Gianna Camiciottoli; Michael H Cho; Craig P Hersh; Kathleen Barnes; Stephen Rennard; Meher Preethi Boorgula; Jennifer Dy; Nadia N Hansel; James D Crapo; Yohannes Tesfaigzi; Alvar Agusti; Edwin K Silverman; Judith Garcia-Aymerich
Journal:  Thorax       Date:  2017-06-21       Impact factor: 9.139

2.  Epidemiology Standardization Project (American Thoracic Society).

Authors:  B G Ferris
Journal:  Am Rev Respir Dis       Date:  1978-12

3.  Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Authors:  John R Hurst; Jørgen Vestbo; Antonio Anzueto; Nicholas Locantore; Hana Müllerova; Ruth Tal-Singer; Bruce Miller; David A Lomas; Alvar Agusti; William Macnee; Peter Calverley; Stephen Rennard; Emiel F M Wouters; Jadwiga A Wedzicha
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

4.  Identification of Chronic Obstructive Pulmonary Disease Axes That Predict All-Cause Mortality: The COPDGene Study.

Authors:  Gregory L Kinney; Stephanie A Santorico; Kendra A Young; Michael H Cho; Peter J Castaldi; Raul San José Estépar; James C Ross; Jennifer G Dy; Barry J Make; Elizabeth A Regan; David A Lynch; Douglas C Everett; Sharon M Lutz; Edwin K Silverman; George R Washko; James D Crapo; John E Hokanson
Journal:  Am J Epidemiol       Date:  2018-10-01       Impact factor: 4.897

5.  Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus.

Authors:  Craig P Hersh; Barry J Make; David A Lynch; R Graham Barr; Russell P Bowler; Peter M A Calverley; Peter J Castaldi; Michael H Cho; Harvey O Coxson; Dawn L DeMeo; Marilyn G Foreman; MeiLan K Han; Benjamin J Harshfield; John E Hokanson; Sharon Lutz; Joe W Ramsdell; Elizabeth A Regan; Stephen I Rennard; Joyce D Schroeder; Frank C Sciurba; Robert M Steiner; Ruth Tal-Singer; Edwin van Beek; Edwin K Silverman; James D Crapo
Journal:  BMC Pulm Med       Date:  2014-10-24       Impact factor: 3.317

  5 in total
  1 in total

Review 1.  Machine Learning Characterization of COPD Subtypes: Insights From the COPDGene Study.

Authors:  Peter J Castaldi; Adel Boueiz; Jeong Yun; Raul San Jose Estepar; James C Ross; George Washko; Michael H Cho; Craig P Hersh; Gregory L Kinney; Kendra A Young; Elizabeth A Regan; David A Lynch; Gerald J Criner; Jennifer G Dy; Stephen I Rennard; Richard Casaburi; Barry J Make; James Crapo; Edwin K Silverman; John E Hokanson
Journal:  Chest       Date:  2019-12-28       Impact factor: 9.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.